Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin injection after biliary sphincterotomy.

A Gorelick1, J Barnett, W Chey

  • 1Connecticut Gastroenterology Consultants, PC, New Haven, Connecticut, USA.

Endoscopy
|February 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus study to support and enhance Parkinson's disease management.

Journal of Parkinson's disease·2026
Same author

Local inhomogeneities resolved by scanning probe techniques and their impact on local 2DEG formation in oxide heterostructures.

Nanoscale advances·2022
Same author

Wastewater-based epidemiology in hazard forecasting and early-warning systems for global health risks.

Environment international·2022
Same author

Radiological-pathological correlation of negative CT biopsy results enables high negative predictive value for thoracic malignancy.

Clinical radiology·2020
Same author

Validation of the British Society of Thoracic Imaging guidelines for COVID-19 chest radiograph reporting.

Clinical radiology·2020
Same author

The mental health impacts of climate change: Findings from a Pacific Island atoll nation.

Journal of anxiety disorders·2020

Botulinum toxin injections may reduce pancreatitis risk after biliary sphincterotomy in patients with sphincter of Oddi dysfunction (SOD). This study found a trend toward fewer pancreatitis cases with botulinum toxin compared to a saline placebo.

Area of Science:

  • Gastroenterology
  • Endoscopic procedures
  • Sphincter of Oddi dysfunction

Background:

  • Endoscopic biliary sphincterotomy for Sphincter of Oddi dysfunction (SOD) carries a high risk of post-ERCP pancreatitis.
  • This risk may stem from persistent pancreatic sphincter hypertension.
  • Botulinum toxin is explored as a method to temporarily alleviate this hypertension.

Purpose of the Study:

  • To investigate if botulinum toxin injection can reduce pancreatic sphincter hypertension.
  • To assess the efficacy of botulinum toxin in lowering the incidence of post-ERCP pancreatitis in SOD patients.

Main Methods:

  • Patients with suspected biliary SOD undergoing ERCP with manometry were enrolled.
  • Those with elevated pressures received either botulinum toxin or a saline sham injection post-biliary sphincterotomy.

Related Experiment Videos

  • Botulinum toxin (50 units) was injected into the pancreatic sphincter.

    • Main Results:

    • 26 patients with elevated pressures were randomized: 12 to botulinum toxin, 14 to sham.
    • Pancreatitis occurred in 3/12 (25%) in the botulinum toxin group versus 6/14 (43%) in the sham group.
    • The difference in pancreatitis rates was not statistically significant (P = 0.34).

    Conclusions:

    • Biliary sphincterotomy in SOD patients without pancreatic protection is risky.
    • Botulinum toxin injection post-biliary sphincterotomy is feasible and safe.
    • A trend towards reduced post-ERCP pancreatitis was observed, warranting further investigation.